Biograil
PrivateLast Round
Series B
Jul 1, 2025
Total Funding Raised
$17.31M
Company Overview
Biograil is a therapeutic devices company that is developing a medical device designed to replace the standard injection system of medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biograil Comparables
Compare Biograil with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rani Therapeutics | 85% | |
| i2O Therapeutics | 81% | |
| Biora Therapeutics | 79% |
Biograil Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 1, 2025 | ||||
| Seed | Apr 5, 2024 | ||||
| Grant | Mar 14, 2022 | ||||
| Seed | Feb 17, 2022 | ||||
| Seed | Jan 15, 2020 |
Key People
Founding team and executive leadership
Biograil Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund Denmark | Grant |
| Verve Ventures | Seed, Series B |
| Sanner Ventures | Seed |
| Roquette Ventures | Seed |
| Evonik Venture Capital | Seed |
| MEGATREND INVEST A/S | Seed, Series B |
| High-Tech Gründerfonds | Seed, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
Monthly visitors grew 195% MoM, reaching 1.2K.
- Jan 24, 2026
Monthly visitors increased 578% MoM, from 58 to 393.
Biograil Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Biograil's valuation, stock price, and market status.
Is Biograil a public or private company?
Biograil is a private company.
What is the current stock price of Biograil?
Biograil is a private company with no public stock price. No recent secondary market data is available.
How much is Biograil worth (valuation)?
Valuation information for Biograil is not publicly available.
Can I buy Biograil stock?
Biograil shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Biograil's last funding round?
Biograil's most recent funding round was Series B on July 1, 2025.
Who are the main investors in Biograil?
Key investors in Biograil include Innovation Fund Denmark, Verve Ventures, MEGATREND INVEST A/S, High-Tech Gründerfonds.
Will Biograil IPO soon?
No public IPO plans have been announced for Biograil.
How can I track Biograil secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biograil's secondary market activity and sign up for updates.